Pacific Sage Partners’s Bristol-Myers Squibb BMY Stock Holding History

Pacific Sage Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Sell	3,749 -550	-13%	-$31.6K	0.03%	118
2026 Q1	$261K	Buy	4,299 +470	+12%	+$27.4K	0.04%	98
2025 Q4	$207K	Buy	+3,829	New	+$184K	0.03%	116
2025 Q2	–	Sell	-3,469	Closed	-$212K	–	113
2025 Q1	$212K	Buy	+3,469	New	+$202K	0.05%	100
2023 Q3	–	Sell	-3,230	Closed	-$207K	–	86
2023 Q2	$207K	Sell	3,230 -575	-15%	-$38.6K	0.06%	81
2023 Q1	$264K	Hold	3,805	–	–	0.08%	69
2022 Q4	$274K	Buy	+3,805	New	+$287K	0.09%	67

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pacific Sage Partners's BMY Position: Q2 2026 in Review

Pacific Sage Partners reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $31.6K and leaving 3,749 shares worth $216K. The position accounts for 0.03% of the portfolio, ranked #118.

Pacific Sage Partners first reported a position in BMY in Q4 2022 and has held it in 7 quarters since. The position peaked at $274K in Q4 2022. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Pacific Sage Partners held 3,749 shares of Bristol-Myers Squibb worth $216K as of Q2 2026.
Pacific Sage Partners sold 550 Bristol-Myers Squibb shares in Q2 2026, an estimated $31.6K.
Bristol-Myers Squibb made up 0.03% of Pacific Sage Partners's portfolio in Q2 2026, its #118 holding.
Pacific Sage Partners first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 7 quarters since.
Pacific Sage Partners's Bristol-Myers Squibb position peaked at $274K in Q4 2022.
2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pacific Sage Partners's 13F filing for Q2 2026, filed 6 Aug 2026.